Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Clinical trial NCT00401323 · COMPLETED

Trial details

NCT number: NCT00401323
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Head and Neck Neoplasms Neoplasm Recurrence, Local Neoplasm Metastasis

Start date: 1998-01-01
Primary completion: 2003-06-01
Enrollment: 568

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.